Health Canada drug identification number

DIN 02561506 — AGAMREE 40 MG

AGAMREE is a suspension of Vamorolone marketed by KYE PHARMACEUTICALS INC.. The full Vamorolone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02561506
Brand name
AGAMREE
Active ingredient
Vamorolone
Strength
40 MG
Dosage form
SUSPENSION
Route
ORAL
Manufacturer
KYE PHARMACEUTICALS INC.
Health Canada status
MARKETED
Drug class
Corticosteroid (glucocorticoid) with dissociative anti-inflammatory activity

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.